Annual EBITDA:
-$450.13M-$89.73M(-24.90%)Summary
- As of today, MDGL annual EBITDA is -$450.13 million, with the most recent change of -$89.73 million (-24.90%) on December 31, 2024.
- During the last 3 years, MDGL annual EBITDA has fallen by -$208.68 million (-86.43%).
- MDGL annual EBITDA is now -642.30% below its all-time high of $83.00 million, reached on December 31, 2009.
Performance
MDGL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$46.83M+$32.11M(+40.68%)Summary
- As of today, MDGL quarterly EBITDA is -$46.83 million, with the most recent change of +$32.11 million (+40.68%) on June 30, 2025.
- Over the past year, MDGL quarterly EBITDA has increased by +$115.44 million (+71.14%).
- MDGL quarterly EBITDA is now -139.42% below its all-time high of $118.78 million, reached on September 30, 2009.
Performance
MDGL Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$308.40M+$115.44M(+27.24%)Summary
- As of today, MDGL TTM EBITDA is -$308.40 million, with the most recent change of +$115.44 million (+27.24%) on June 30, 2025.
- Over the past year, MDGL TTM EBITDA has increased by +$221.18 million (+41.76%).
- MDGL TTM EBITDA is now -422.03% below its all-time high of $95.77 million, reached on March 31, 2010.
Performance
MDGL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MDGL EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -24.9% | +71.1% | +41.8% |
| 3Y3 Years | -86.4% | +33.3% | -20.8% |
| 5Y5 Years | -374.5% | +6.8% | -74.5% |
MDGL EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -86.4% | at low | at high | +71.1% | -13.2% | +43.6% |
| 5Y | 5-Year | -374.5% | at low | at high | +71.1% | -74.5% | +43.6% |
| All-Time | All-Time | -642.3% | at low | -139.4% | +71.1% | -422.0% | +43.6% |
MDGL EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$46.83M(+40.7%) | -$308.40M(+27.2%) |
| Mar 2025 | - | -$78.93M(-18.5%) | -$423.84M(+14.7%) |
| Dec 2024 | -$450.13M(-24.9%) | -$66.63M(+42.6%) | -$496.78M(+9.2%) |
| Sep 2024 | - | -$116.01M(+28.5%) | -$547.18M(-3.3%) |
| Jun 2024 | - | -$162.27M(-6.8%) | -$529.57M(-16.7%) |
| Mar 2024 | - | -$151.87M(-29.8%) | -$453.63M(-19.4%) |
| Dec 2023 | -$360.39M(-23.9%) | -$117.03M(-18.9%) | -$379.97M(-9.2%) |
| Sep 2023 | - | -$98.40M(-14.0%) | -$348.11M(-5.5%) |
| Jun 2023 | - | -$86.32M(-10.4%) | -$330.00M(-5.1%) |
| Mar 2023 | - | -$78.21M(+8.2%) | -$313.84M(-7.1%) |
| Dec 2022 | -$290.92M(-20.5%) | -$85.17M(-6.1%) | -$293.10M(-7.6%) |
| Sep 2022 | - | -$80.29M(-14.4%) | -$272.43M(-6.8%) |
| Jun 2022 | - | -$70.16M(-22.1%) | -$255.20M(-3.4%) |
| Mar 2022 | - | -$57.48M(+10.9%) | -$246.69M(-1.9%) |
| Dec 2021 | -$241.44M(-17.1%) | -$64.50M(-2.3%) | -$242.08M(-2.1%) |
| Sep 2021 | - | -$63.06M(-2.3%) | -$237.02M(-1.9%) |
| Jun 2021 | - | -$61.65M(-16.6%) | -$232.63M(-5.2%) |
| Mar 2021 | - | -$52.87M(+11.1%) | -$221.19M(-7.3%) |
| Dec 2020 | -$206.20M(-117.4%) | -$59.44M(-1.3%) | -$206.20M(-16.7%) |
| Sep 2020 | - | -$58.67M(-16.8%) | -$176.69M(-24.3%) |
| Jun 2020 | - | -$50.21M(-32.6%) | -$142.19M(-24.0%) |
| Mar 2020 | - | -$37.88M(-26.6%) | -$114.65M(-20.9%) |
| Dec 2019 | -$94.86M(-133.7%) | -$29.93M(-23.8%) | -$94.86M(-19.5%) |
| Sep 2019 | - | -$24.17M(-6.6%) | -$79.36M(-19.3%) |
| Jun 2019 | - | -$22.68M(-25.3%) | -$66.50M(-28.8%) |
| Mar 2019 | - | -$18.09M(-25.4%) | -$51.63M(-27.2%) |
| Dec 2018 | -$40.59M(-26.9%) | -$14.43M(-27.6%) | -$40.59M(-15.9%) |
| Sep 2018 | - | -$11.31M(-45.0%) | -$35.01M(-8.3%) |
| Jun 2018 | - | -$7.80M(-10.7%) | -$32.33M(+1.9%) |
| Mar 2018 | - | -$7.05M(+20.4%) | -$32.96M(-3.0%) |
| Dec 2017 | -$31.98M(-27.1%) | -$8.85M(-2.6%) | -$31.98M(-38.3%) |
| Sep 2017 | - | -$8.63M(-2.3%) | -$23.13M(+18.7%) |
| Jun 2017 | - | -$8.43M(-38.8%) | -$28.47M(-21.5%) |
| Mar 2017 | - | -$6.08M(+56.5%) | -$23.43M(+5.4%) |
| Dec 2016 | -$25.18M(-678.7%) | - | - |
| Sep 2016 | - | -$13.96M(-311.4%) | -$24.77M(-112.2%) |
| Jun 2016 | - | -$3.39M(+47.0%) | -$11.67M(+57.7%) |
| Mar 2016 | - | -$6.40M(-529.8%) | -$27.61M(+33.3%) |
| Dec 2015 | -$3.23M(+96.1%) | -$1.02M(-18.2%) | -$41.38M(+31.1%) |
| Sep 2015 | - | -$860.00K(+95.6%) | -$60.08M(+23.5%) |
| Jun 2015 | - | -$19.34M(+4.1%) | -$78.51M(+2.7%) |
| Mar 2015 | - | -$20.16M(-2.2%) | -$80.70M(+3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | -$83.28M(+4.3%) | -$19.73M(-2.3%) | -$83.28M(+4.1%) |
| Sep 2014 | - | -$19.28M(+10.4%) | -$86.85M(+2.6%) |
| Jun 2014 | - | -$21.53M(+5.3%) | -$89.22M(+0.5%) |
| Mar 2014 | - | -$22.74M(+2.4%) | -$89.62M(-3.0%) |
| Dec 2013 | -$87.04M(-44.6%) | -$23.30M(-7.6%) | -$87.04M(-7.0%) |
| Sep 2013 | - | -$21.65M(+1.3%) | -$81.33M(-9.8%) |
| Jun 2013 | - | -$21.94M(-8.8%) | -$74.05M(-11.8%) |
| Mar 2013 | - | -$20.16M(-14.6%) | -$66.25M(-9.4%) |
| Dec 2012 | -$60.20M(-36.9%) | -$17.59M(-22.4%) | -$60.57M(-14.4%) |
| Sep 2012 | - | -$14.37M(-1.7%) | -$52.93M(-5.0%) |
| Jun 2012 | - | -$14.13M(+2.4%) | -$50.43M(-5.2%) |
| Mar 2012 | - | -$14.48M(-45.6%) | -$47.92M(-9.0%) |
| Dec 2011 | -$43.97M(-25.7%) | -$9.95M(+16.2%) | -$43.97M(-4.9%) |
| Sep 2011 | - | -$11.87M(-2.1%) | -$41.92M(-5.3%) |
| Jun 2011 | - | -$11.63M(-10.4%) | -$39.81M(-8.3%) |
| Mar 2011 | - | -$10.53M(-33.2%) | -$36.75M(-5.1%) |
| Dec 2010 | -$34.97M(-142.1%) | -$7.90M(+19.0%) | -$34.97M(-4.3%) |
| Sep 2010 | - | -$9.76M(-14.0%) | -$33.53M(-135.3%) |
| Jun 2010 | - | -$8.56M(+2.1%) | $95.01M(-0.8%) |
| Mar 2010 | - | -$8.74M(-35.2%) | $95.77M(+13.7%) |
| Dec 2009 | $83.00M(+191.2%) | -$6.46M(-105.4%) | $84.24M(+28.6%) |
| Sep 2009 | - | $118.78M(+1622.4%) | $65.52M(+183.0%) |
| Jun 2009 | - | -$7.80M(+61.5%) | -$78.98M(+15.5%) |
| Mar 2009 | - | -$20.27M(+19.5%) | -$93.49M(-2.8%) |
| Dec 2008 | -$90.99M(-44.7%) | -$25.18M(+2.1%) | -$90.99M(-12.0%) |
| Sep 2008 | - | -$25.72M(-15.2%) | -$81.27M(-15.9%) |
| Jun 2008 | - | -$22.32M(-25.6%) | -$70.12M(-8.9%) |
| Mar 2008 | - | -$17.77M(-14.9%) | -$64.42M(-2.5%) |
| Dec 2007 | -$62.87M(-13.3%) | -$15.46M(-6.2%) | -$62.86M(-5.5%) |
| Sep 2007 | - | -$14.57M(+12.3%) | -$59.58M(-1.5%) |
| Jun 2007 | - | -$16.62M(-2.5%) | -$58.68M(-4.7%) |
| Mar 2007 | - | -$16.21M(-33.1%) | -$56.05M(-1.0%) |
| Dec 2006 | -$55.50M(+19.2%) | -$12.18M(+10.9%) | -$55.50M(-28.1%) |
| Sep 2006 | - | -$13.67M(+2.2%) | -$43.32M(-46.1%) |
| Jun 2006 | - | -$13.98M(+10.7%) | -$29.65M(-89.3%) |
| Mar 2006 | - | -$15.66M(+13.3%) | -$15.66M(+13.3%) |
| Dec 2005 | -$68.72M(-56.9%) | - | - |
| Mar 2005 | - | -$18.07M(-231.4%) | -$18.07M(-231.4%) |
| Dec 2004 | -$43.80M(-60.5%) | - | - |
| Mar 2004 | - | -$5.45M | -$5.45M |
| Dec 2003 | -$27.29M(-274.2%) | - | - |
| Dec 2002 | -$7.29M(-1718.5%) | - | - |
| Dec 2001 | -$401.00K | - | - |
FAQ
- What is Madrigal Pharmaceuticals, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is Madrigal Pharmaceuticals, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is Madrigal Pharmaceuticals, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Madrigal Pharmaceuticals, Inc.?
- What is Madrigal Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is Madrigal Pharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of MDGL is -$450.13M
What is the all-time high annual EBITDA for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high annual EBITDA is $83.00M
What is Madrigal Pharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, MDGL annual EBITDA has changed by -$89.73M (-24.90%)
What is Madrigal Pharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of MDGL is -$46.83M
What is the all-time high quarterly EBITDA for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high quarterly EBITDA is $118.78M
What is Madrigal Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, MDGL quarterly EBITDA has changed by +$115.44M (+71.14%)
What is Madrigal Pharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of MDGL is -$308.40M
What is the all-time high TTM EBITDA for Madrigal Pharmaceuticals, Inc.?
Madrigal Pharmaceuticals, Inc. all-time high TTM EBITDA is $95.77M
What is Madrigal Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, MDGL TTM EBITDA has changed by +$221.18M (+41.76%)